Facebook
Twitter
ВКонтакте
Telegram
Сообщить о неточностиКвартальный отчет 2024-Q2
добавлен 05.08.2024
Axsome Therapeutics Мультипликаторы 2011-2024 | AXSM
Мультипликаторы по годам Axsome Therapeutics
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
P/E |
-15.0 | -17.2 | -7.9 | -24.7 | -44.0 | -7.2 | -2.2 | -3.3 | -8.9 | - | - | - | - |
P/S |
13.3 | 64.2 | - | - | - | - | - | - | - | - | - | - | - |
EPS |
-5.3 | -4.6 | -3.5 | -2.8 | -2.0 | -1.1 | -1.3 | -1.4 | -1.0 | -0.7 | - | - | - |
EV (Enterprise Value) |
3.6 млрд | 3.23 млрд | 1.02 млрд | 2.43 млрд | 2.83 млрд | 224 млн | 48.6 млн | 70 млн | 48.1 млн | 3.37 млн | 4.13 млн | - | - |
EBITDA per Share |
-5.09 | -4.42 | -3.31 | -2.65 | -1.97 | -1.21 | -1.18 | -1.41 | -0.579 | - | - | - | - |
EV/EBITDA |
-8.0 | -24.3 | -41.9 | -6.7 | -1.5 | -2.3 | -6.6 | - | - | - | - | ||
PEG |
-0.44 | -0.54 | -0.37 | 0.49 | 0.59 | -0.77 | -0.21 | 0.05 | 0.1 | - | - | - | - |
P/B |
18.8 | 29.3 | 66.0 | 22.3 | 16.8 | 238.8 | 3.8 | 4.2 | 2.0 | - | - | - | - |
P/CF |
-24.7 | -27.6 | -9.5 | -32.4 | -64.8 | -7.4 | -2.4 | -4.2 | -12.5 | - | - | - | - |
ROE % |
-125.27 | -170.81 | -834.26 | -90.43 | -38.24 | -3301.50 | -173.14 | -126.10 | -22.74 | - | - | - | - |
ROA % |
-40.67 | -56.45 | -148.55 | -55.28 | -30.99 | -201.35 | -81.40 | -71.19 | -21.52 | - | - | - | - |
ROCE % |
-121.39 | -164.12 | -797.82 | -60.90 | -34.23 | -715.97 | -115.30 | -87.20 | -19.80 | - | - | - | - |
Current Ratio |
1.5 | 1.5 | 1.2 | 7.9 | 9.0 | 1.4 | 2.9 | 5.3 | 18.6 | - | - | - | - |
DSO |
89.4 | 137.5 | - | - | - | - | - | - | - | - | - | - | - |
DIO |
136.2 | 151.7 | - | - | - | - | - | - | - | - | - | - | - |
DPO |
555.1 | 1817.1 | - | - | - | - | - | - | - | - | - | - | - |
Операционный цикл |
225.6 | 289.2 | - | - | - | - | - | - | - | - | - | - | - |
Финансовый цикл |
-329.5 | -1527.9 | - | - | - | - | - | - | - | - | - | - | - |
Все данные представлены в валюте USD
Мультипликаторы поквартально Axsome Therapeutics
| 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EPS |
-1.67 | -1.44 | - | -1.32 | -1.54 | -0.26 | - | -1.07 | -1.06 | -1.06 | - | -0.93 | -0.86 | -0.78 | -0.79 | -0.61 | -0.49 | -0.88 | -0.71 | -0.56 | -0.41 | -0.32 | -0.32 | -0.31 | -0.32 | -0.19 | -0.31 | -0.27 | -0.3 | -0.41 | -0.38 | -0.38 | -0.36 | -0.31 | -0.23 | -0.41 | -0.19 | -0.19 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA per Share |
-1.61 | -1.42 | - | -1.28 | -1.45 | -0.14 | - | -0.98 | -0.98 | -1 | - | -0.89 | -0.82 | -0.74 | - | -0.57 | -0.48 | -0.88 | - | -0.55 | -0.4 | -0.31 | 0.31 | -0.31 | -0.31 | -0.28 | 0.25 | 0.27 | 0.29 | 0.39 | 0.4 | 0.38 | 0.36 | 0.31 | 0.16 | 0.18 | 0.19 | 0.17 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROE % |
-170.76 | -117.71 | -57.20 | -85.69 | -91.09 | -339.62 | -570.74 | -652.40 | -705.58 | -478.15 | -157.24 | -182.87 | -121.35 | -92.27 | -90.43 | -78.68 | -69.24 | -60.83 | -38.24 | -1047.58 | -1919.89 | -2795.09 | -3301.50 | -2322.73 | -1478.20 | -637.67 | -173.14 | -162.66 | -157.53 | -146.73 | -126.10 | -99.37 | -75.87 | -48.88 | -26.29 | -19.05 | -9.19 | -4.61 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROA % |
-47.70 | -44.21 | -21.33 | -34.56 | -37.43 | -49.40 | -80.93 | -110.84 | -127.54 | -127.12 | -69.98 | -85.65 | -68.05 | -55.36 | -55.28 | -50.86 | -47.22 | -43.62 | -30.99 | -82.14 | -127.32 | -174.92 | -201.35 | -159.84 | -124.08 | -90.16 | -81.40 | -79.68 | -80.42 | -78.32 | -71.19 | -58.86 | -49.36 | -35.87 | -24.88 | -18.02 | -8.70 | -4.36 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROCE % |
-168.69 | -116.14 | -52.08 | -79.04 | -82.94 | -317.37 | -545.23 | -623.43 | -674.68 | -460.09 | -150.30 | -168.87 | -109.23 | -81.67 | -62.74 | -73.34 | -65.38 | -57.28 | -23.96 | 983.62 | 115.32 | -729.00 | -1486.90 | -2455.93 | -1539.36 | -647.13 | 162.49 | 159.30 | 155.04 | 146.31 | 127.69 | 99.13 | 70.07 | 42.91 | 19.80 | 13.01 | 8.65 | 4.16 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Current Ratio |
1.2 | 1.4 | 1.5 | 1.8 | 1.8 | - | 1.5 | 1.9 | 1.1 | 1.2 | 1.2 | 1.6 | 2.0 | 2.4 | 2.6 | 2.6 | 2.6 | 2.6 | 5.3 | 5.3 | 5.3 | 5.3 | 1.1 | 1.1 | 1.1 | 1.1 | 1.9 | 1.9 | 1.9 | 1.9 | 2.3 | 2.3 | 2.3 | 2.3 | 18.6 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DSO |
116.1 | 119.4 | - | 115.1 | - | - | - | 98.8 | 83.6 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DIO |
174.5 | 222.6 | - | 134.4 | - | - | - | 294.7 | 479.2 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
652.1 | 684.5 | - | 503.3 | - | - | - | 765.4 | 1486.5 | - | - | - | 1196.9 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Операционный цикл |
290.6 | 342.0 | - | 249.5 | - | - | - | 393.5 | 562.8 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Финансовый цикл |
-361.6 | -342.5 | - | -253.8 | - | - | - | -371.9 | -923.6 | - | - | - | -1196.9 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Все данные представлены в валюте USD